Neurotech startup Precision Neuroscience announced Thursday it has acquired a factory in Dallas, where it will build the key component of its brain implant, the Layer 7 Cortical Interface. It will help the company accelerate development and get closer to the regulatory approval it hopes to obtain in 2024.

It believes that its brain implant could eventually allow paralyzed patients to operate digital devices using their brain signals. The company is currently testing the implant on human patients. The manufacturing plant is the only facility capable of producing Precision’s “sophisticated” electrode arrays.

It allows us to iterate really quickly, improve performance, longevity, and different form factors of the device, all things that we’ve always wanted, can now be implemented much faster,” co-founder and CEO Michael Mager told a media outlet. 

Precision’s electrode array is thinner than a human hair and could easily be mistaken for Scotch tape. With its flexible design, the system can rest on the brain’s surface and generate a real-time, high-resolution rendering of neural activity without damaging any tissues.

Precision is developing its technology alongside other companies like Synchron, Paradromics, Blackrock Neurotech, and Elon Musk’s Neuralink in the fast-growing brain-computer interface (BCI) industry. Dr. Benjamin Rapoport, Precision’s co-founder and chief science officer, also co-founded Neuralink before departing in 2018.

The high profile of Musk, the CEO of Tesla and SpaceX, has made Neuralink one of the most known companies in the BCI space. With its implant, the company takes a more invasive approach than Precision. The technology is also manufactured in-house by Neuralink.